Opening Plenary Session

Speaker(s):

• Joerg Zimmermann, Vetter Pharma-Fertigung GmbH & Co., Vice President, Vetter Development Service, External Affairs
• Thomas B. Hartman, President and CEO, ISPE
• Paul A. Gustafson, 2022-2023 PIC/S Chair, Sr. Corporate Regulatory Compliance & Enforcement Advisor, Regulatory Operations and Enforcement Branch (ROEB), Health Canada
• Mr. Michael G. Higgins, Sr. Director External Engagement and Supplier Quality, Moderna Therapeutics
• Alonza Cruse, Director, Office of Pharmaceutical Quality Operations, FDA/ORA